Genexa announced today that Health Canada has granted it a temporary exception to import a limited quantity of its Pediatric Pain and Fever medication (acetaminophen 160 mg per 5 mL oral suspension) from its supply network. in the USA.
ATLANTA, Feb. 16. 2, 2023 /CNW/ — Genexa Childhood Pain and Fever is intended for children ages 2 to 11 to temporarily lower fever and provide temporary relief from various cold and flu symptoms.
Genexa, a clean medicine company, is temporarily making its Children’s Pain and Fever product available to major retailers across Canada to help address the current shortages of children’s pain relievers across the country.
“Genexa is proud to support Canadian families and children. As the need for access to medicines for children has increased in Canada, we are pleased to work with Health Canada to be able to provide a limited supply of our pain and fever medicines for children to help alleviate current shortages” , said David Johnson, CEO and co-founder of Genexa. “We are committed to helping our northern neighbors and continue to work closely with Health Canada to secure longer-term approval as well as to bring additional formulations and products to Canada. »
For a complete list of retailers in Canada that carry Genexa Pediatric Pain and Fever, please visit www.genexa.ca/english. Please call or check online with your local retailers to determine product availability in your area, as product distribution to stores across Canada is underway.
For further information regarding the labeling and dosage of Genexa Pediatric Pain and Fever, please visit the following site www.genexa.ca/francais.
Health Index publication: 2023-02-16 – Number of visits since publication: 10
To read on Health Index:
